[go: up one dir, main page]

PE20081312A1 - MACROCYCLIC TETRAZOLYLS AS SERINE PROTEASE INHIBITORS OF HEPATITIS C - Google Patents

MACROCYCLIC TETRAZOLYLS AS SERINE PROTEASE INHIBITORS OF HEPATITIS C

Info

Publication number
PE20081312A1
PE20081312A1 PE2007001035A PE2007001035A PE20081312A1 PE 20081312 A1 PE20081312 A1 PE 20081312A1 PE 2007001035 A PE2007001035 A PE 2007001035A PE 2007001035 A PE2007001035 A PE 2007001035A PE 20081312 A1 PE20081312 A1 PE 20081312A1
Authority
PE
Peru
Prior art keywords
hepatitis
macrocyclic
aryl
serine protease
tetrazolyls
Prior art date
Application number
PE2007001035A
Other languages
Spanish (es)
Inventor
Ying Sun
Dong Liu
Yat Sun Or
Zhe Wang
Original Assignee
Enanta Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enanta Pharm Inc filed Critical Enanta Pharm Inc
Publication of PE20081312A1 publication Critical patent/PE20081312A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A COMPUESTOS DE TETRAZOLILOS MACROCICLICOS DE FORMULAS (I),(II),(III),(IV),(V),(VI),(VII) O (VIII), EN DONDE A ES R1, -(C=O)-O-R1, -C(=O)-NH-R2, ENTRE OTROS; R1 ES ARILO, HETEROARILO, HETEROCICLOALQUILO, ENTRE OTROS; G ES NSH(O)2-R3 Y NH(SO)2NR4R5; R3 ES ARILO, HETEROARILO, HETEROCICLOALQUILO, ENTRE OTROS; R4 Y R5 SON INDEPENDIENTEMENTE H, ARILO, HETEROCICLOALQUILO, ENTRE OTROS; L ES-CH2-, -O-, -S- Y -S(O)2-; X ES H, ARILO, HETEROARILO, ENTRE OTROS; j ES 0,1,2,3 O 4; k ES 1,2 O 3; m ES 0,1 O 2; n ES 1,2 O 3. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON INHIBIDORES DE SERINA PROTEASA, PARTICULARMENTE LA ACTIVIDAD DE LA NS3-NS4A PROTEASA DEL VIRUS DE HEPATITIS C (VHC) SIENDO UTILES EN EL TRATAMIENTO DE HEPATITIS C Y COMO AGENTES ANTIVIRALESREFERS TO MACROCYCLIC TETRAZOLYL COMPOUNDS OF FORMULAS (I), (II), (III), (IV), (V), (VI), (VII) OR (VIII), WHERE A IS R1, - (C = O) -O-R1, -C (= O) -NH-R2, AMONG OTHERS; R1 IS ARYL, HETEROARYL, HETEROCYCLOALKYL, AMONG OTHERS; G IS NSH (O) 2-R3 AND NH (SO) 2NR4R5; R3 IS ARYL, HETEROARIL, HETEROCYCLOALKYL, AMONG OTHERS; R4 AND R5 ARE INDEPENDENTLY H, ARYL, HETEROCICLOALKYL, AMONG OTHERS; L IS-CH2-, -O-, -S- AND -S (O) 2-; X IS H, ARYL, HETEROARYL, AMONG OTHERS; j ES 0,1,2,3 O 4; k IS 1,2 O 3; m IS 0.1 O 2; n IS 1,2 OR 3. ALSO REFERS TO A PHARMACEUTICAL COMPOSITION AND A PREPARATION PROCEDURE. THESE COMPOUNDS ARE INHIBITORS OF SERINE PROTEASE, PARTICULARLY THE ACTIVITY OF THE NS3-NS4A PROTEASE OF THE HEPATITIS C VIRUS (HCV), BEING USEFUL IN THE TREATMENT OF HEPATITIS C AND AS ANTIVIRAL AGENTS

PE2007001035A 2006-08-04 2007-08-06 MACROCYCLIC TETRAZOLYLS AS SERINE PROTEASE INHIBITORS OF HEPATITIS C PE20081312A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49924506A 2006-08-04 2006-08-04

Publications (1)

Publication Number Publication Date
PE20081312A1 true PE20081312A1 (en) 2008-09-17

Family

ID=40981968

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001035A PE20081312A1 (en) 2006-08-04 2007-08-06 MACROCYCLIC TETRAZOLYLS AS SERINE PROTEASE INHIBITORS OF HEPATITIS C

Country Status (3)

Country Link
CO (1) CO6020003A1 (en)
PE (1) PE20081312A1 (en)
TW (1) TW200920394A (en)

Also Published As

Publication number Publication date
CO6020003A1 (en) 2009-03-31
TW200920394A (en) 2009-05-16

Similar Documents

Publication Publication Date Title
PE20051150A1 (en) SULFURED COMPOUNDS AS INHIBITORS OF THE SERINE PROTEASE NS3 OF THE HEPATITIS C VIRUS
PE20050940A1 (en) NEW INHIBITORS OF THE HEPATITIS C VIRUS NS3 / NS4A SERINE PROTEASE
CY1107200T1 (en) SUSPITUS SUSPENSION UNITS C
CL2011002016A1 (en) Compounds derived from benzimidazole with inhibitory activity of the function of the ns5a protein encoded by the hepatitis c virus (vhc); pharmaceutical composition that includes them; Useful in the treatment of an infection with the hepatitis c virus (vhc).
PE20080992A1 (en) QUINOXALINYL MACROCYCLIC SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
PE20080457A1 (en) MACROCYCLIC OXIMYL COMPOUNDS INHIBITORS OF HEPATITIS C PROTEASES
PE20081792A1 (en) SERINE PROTEASE INHIBITORS
EP1771454A4 (en) PEPTIDE ANALOGUES INHIBITORS OF HEPATITIS C
PE20050999A1 (en) NOVEL KETOAMIDES WITH CYCLIC P4 AS INHIBITORS OF NS3 SERINE PROTEASE FROM HEPATITIS C VIRUS
MY148123A (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
JO2593B1 (en) HCV NS3 Protease Inhibitors
PE20121479A1 (en) HEPATITIS C VIRUS INHIBITORS
SG159385A1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
NO20081086L (en) Macrocyclic peptides as HCV NS3 protease inhibitors
PE20121157A1 (en) HETEROCYCLIC COMPOUNDS AS INHIBITORS OF SERINE PROTEASES
PE20091237A1 (en) PYRROLIDINE DERIVATIVES AS MODULATORS OF SERINE PROTEASES
MY164469A (en) Hcv ns3 protease inhibitors
PE20070115A1 (en) DERIVATIVES OF [1,3,5] -TRIAZINE AS INHIBITORS OF ASPARTILE PROTEASES
UY29704A1 (en) MACROCICLIC INHIBITORS OF HEPATITIS C VIRUS
UA116616C2 (en) HCV SERINE PROTEASE INHIBITORS RECEIVED FROM MACROCYCLIC PROLINE
UY28423A1 (en) INHIBITORS OF SERINE PROTEASES, IN SPECIAL PROTEASA NS3-NS4A OF HCV.-
UY29016A1 (en) ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C
ATE349463T1 (en) BRIDGED BIZYCLIC SERINE PROTEASE INHIBITORS
ATE526341T1 (en) MACROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS
WO2005037860A3 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease

Legal Events

Date Code Title Description
FA Abandonment or withdrawal